pneumocystis jirovecii pneumonia and human immunodeficiency virus coinfection in western iran

Background: the human immunodeficiency virus (hiv) is one of the greatest health challenges facing worldwide. the virus suppresses the immune system of the patient. the purpose of this study was to describe the epidemiology of pneumocystis jirovecii colonization, rarely found in normal people, in patients with stage 4 hiv infection in kermanshah, iran, from mar 1995 to feb 2016.methods: in this retrospective study, we surveyed medical records of stage 4 hivpositive patients with pneumocystis admitted to behavioral counseling center of kermanshah. several parameters were analyzed including demographic characteristics, body mass index (bmi), treatment regimen, diagnostic methods, presenting signs and symptoms, presence of copathogens (bacteria, viruses, or fungi), and nadir of cd4 tcell count before and after treatment.results: during the study period, 114 hivpositive patients were analyzed, of whom 93 were male and 21 were female, respectively. of 114 cases, 26 (22.8%) patients had pneumocystis. all 26 colonized patients had cd4 cell counts below 200 cells/mm3 (range 9–186). the median cd4 count increased from 91 cells/mm3 pre trimethoprim/sulfamethoxazole (tmp/smx) to an estimated 263 cells/mm3 after starting (tmp/smx). bmi was normal in the majority of the patients (85%) and coughs, sputum, and chest pain (19; 73%) followed by dyspnea, weakness, and lethargy (7; 27%) were the most common presentations of fungal pneumonia.conclusion: hiv/aidsinfected patients are an environmental reservoir of p. jirovecii infection that might transmit the infection from one person to another via the airborne route. in addition, rapid identification of such individuals may reduce the morbidity and mortality rate of this disease.